We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Neurology

Journal Scan / Research · December 01, 2021

Effect of Methylphenidate on Apathy in Alzheimer Disease

JAMA Neurology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Neurology
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial
JAMA Neurol 2021 Nov 01;78(11)1324-1332, J Mintzer, KL Lanctôt, RW Scherer, PB Rosenberg, N Herrmann, CH van Dyck, PR Padala, O Brawman-Mintzer, AP Porsteinsson, AJ Lerner, S Craft, AI Levey, W Burke, J Perin, D Shade

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading